Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Blue Cross Blue Shield of Massachusetts and Point32Health are discontinuing coverage of GLP-1 medications for weight loss, and CVS Caremark has restricted its formulary to Wegovy, removing Zepbound
Available: [40] Pharmacology Rounds: GLP-1 Receptor Agonists Part 2, EM:RAP
Sanofi Position: Has historically worked in the GLP-1 space (with drugs like liraglutide, lixisenatide) and is now focusing on metabolic disease innovation and new partnerships
Retrieved from Muroyama K, Murosaki S, Yamamoto Y, Odaka H, Chung HC, Miyoshi M
US$ 25.99
US$ 27.30
US$ 24.93
US$ 27.96
